GO
Loading...

Government Agencies

More

  • WASHINGTON, June 6- The U.S. Food and Drug Administration said on Friday it approved Biogen Idec Inc's long-lasting hemophilia A drug, Eloctate, adding another product to the company's nascent portfolio of drugs for non-malignant blood disorders. The FDA's ruling followed its approval in March of Biogen's hemophilia B treatment, Alprolix.

  • Here's your chance to follow the CIA Friday, 6 Jun 2014 | 2:55 PM ET

    The CIA has a Twitter account—and a sense of humor, apparently, NBC News reports.

  • NEW YORK, June 6- The U.S. dollar recouped losses Friday as investors added to a well-worn pattern of borrowing greenbacks to buy higher-yielding currencies after solid U.S. jobs data left little chance the Federal Reserve would speed up monetary tightening.

  • INVESTMENT FOCUS -Exploiting the ECB-Fed policy gap Friday, 6 Jun 2014 | 10:19 AM ET

    LONDON, June 6- If it wasn't fully apparent before Thursday, it's crystal clear now: the central banks of the euro zone and United States, the two most powerful monetary authorities in the world, are moving in opposite directions.

  • Senators make veterans deal; 18 deaths confirmed Friday, 6 Jun 2014 | 8:39 AM ET
    Sen. John McCain (R-AZ) talks to reporters after a closed door briefing June 4, 2014 on Capitol Hill in Washington.

    As the Senate made a deal to ease delays, the VA's acting boss revealed 18 veterans on a secret waiting list died while waiting for care.

  • LONDON, June 6- Federal Reserve Governor Jerome Powell said on Friday that he wanted to see signs that the U.S. economy was tightening up before before interest rates could be raised. While acknowledging that employment in the United States had rebounded, Powell highlighted "significant" slack, referring to unemployed or underutilized workers.

  • LONDON, June 6- Federal Reserve Governor Jerome Powell said on Friday that the U.S. central bank's forward guidance on interest rates has boosted the U.S. economy by keeping medium- and long-term borrowing costs lower than they otherwise would have been.

  • BOSTON/ SAN FRANCISCO, June 5- A pair of Federal Reserve officials on Wednesday warned that raising U.S. interest rates to fend off bubbles and other troubling signs of financial market unrest could undercut the Fed's efforts to put the U.S. economy on a sounder footing.

  • WASHINGTON, June 5- U.S. household net worth nudged up 2 percent to a record high $81.8 trillion in the first quarter as the stock market continued its upward climb and property values rose, data from the Federal Reserve showed on Thursday.

  • Halozyme shares jump after FDA lifts hold on trial Thursday, 5 Jun 2014 | 7:52 AM ET

    June 5- Shares of Halozyme Therapeutics Inc jumped about 11 percent a day after the U.S. Food and Drug Administration lifted a hold on a trial testing an advanced version of the company's flagship drug delivery technology.

  • WASHINGTON, June 4- Kentucky may be well positioned to meet a carbon emission target for power plants set by federal regulators, even as U.S. Senate candidates there blast the plan, saying it will cripple the state's coal industry. The result: the Bluegrass State may be able to meet EPA targets between now and 2030..

  • NEW YORK/ WASHINGTON, June 4- The Federal Reserve may scrap elements of international measures aimed at assessing bank health in favor of imposing its own rules, frustrating bankers who have spent billions of dollars retooling their books to meet global standards.

  • June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. HeartWare has also been asked to address issues related to its production and quality procedures and fix problems cited in FDA's inspection.

  • Medical device maker HeartWare gets FDA warning letter Wednesday, 4 Jun 2014 | 7:37 AM ET

    June 4- HeartWare International Inc said it received a warning letter from the U.S. Food and Drug Administration following an inspection of its manufacturing plant in Florida in January. The FDA has not restricted the use of HeartWare devices, the company said in a statement.

  • Under Basel, banks can determine how much debt they can take on by using their own models and computer systems to calculate how risky their assets are, among other methods. In other words, the Basel rules give banks a chance to monkey with their risk models to boost profit.

  • WASHINGTON, June 3- The U.S. Senate on Tuesday confirmed Timothy Massad as the new chairman of the U.S. Commodity Futures Trading Commission and approved two others as commissioners, filling a leadership gap at the nation's derivatives regulator. The Senate confirmed Massad and industry veteran Chris Giancarlo by voice vote.

  • U.S. Senate confirms Massad as new CFTC chairman Tuesday, 3 Jun 2014 | 5:49 PM ET

    WASHINGTON, June 3- The U.S. Senate on Tuesday confirmed Treasury Department official Timothy Massad to be chairman of the U.S. Commodity Futures Trading Commission. Senators also confirmed Chris Giancarlo, a swaps industry veteran, as a member of the five-person commission. Both were approved by a voice vote in the Senate.

  • U.S. SENATE CONFIRMS TIMOTHY MASSAD AS CHAIRMAN OF THE U.S.

  • UPDATE 2-U.S. Senate votes to confirm Bowen to CFTC Tuesday, 3 Jun 2014 | 5:16 PM ET

    WASHINGTON, June 3- The U.S. Senate voted on Tuesday to confirm New York lawyer Sharon Bowen as a member of the U.S. Commodity Futures Trading Commission. Treasury official Timothy Massad and Chris Giancarlo, a senior official at derivatives broker GFI in New York, were approved by a Senate panel but have not yet been considered by the full body.

  • June 3- Richard Fisher, a top U.S. Federal Reserve official, said on Tuesday he would favor ending the Fed's massive bond-buying program in October, but he does not expect the central bank to start raising interest rates until next year.